Clinical Trial Update: Effect of PRM-125 on Ambulatory Blood Pressure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PRM-125 for ambulatory blood pressure was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• PRM-125

Snippet

Sponsor: PRM Pharma, LLC | Conditions: Hypertension | Phase 3 | Status: WITHDRAWN